术前MRI强化类型能否反映浸润性乳腺癌的预后因素与手术结局
回顾性分析313例患者315个浸润性乳腺癌术前的MRI强化类型,分为肿块型、非肿块型和混合型。非肿块型浸润性肿瘤最小且HER2阳性最常见;混合型最常伴脉管侵犯、腋窝淋巴结阳性、手术方式改变和首次切缘阳性。HER2状态和手术方式改变在多因素分析中无统计学意义。
要点
- 术前MRI强化类型分为肿块型(62.9%)、非肿块型(18.7%)和混合型(18.4%)。
- 混合型强化与脉管侵犯、腋窝淋巴结阳性、手术方式改变及首次切缘阳性相关。
- 非肿块型强化者浸润性肿瘤尺寸最小,HER2受体阳性状态最常见。
核心结论
- 术前MRI强化类型可反映浸润性乳腺癌不同的预后因素和手术结局。
- 混合型(肿块与非肿块强化并存)可能与更差预后和更差手术结局相关。
研究设计与样本
- 回顾性研究,纳入2014年10月至2017年7月间484例连续术前乳腺MRI患者中最终接受手术的313例患者共315个浸润性乳腺癌病灶。
- 由两名放射科医师回顾性阅片,按强化特征将病灶分为肿块型、非肿块型和混合型,混合型定义为肿块与非肿块强化并存。
- 以组织病理学预后因素和手术结局为参照,采用Pearson卡方、线性对线性关联、Kruskal-Wallis、单因素方差分析和多项logistic回归进行比较。
关键影像表现/征象
- 肿块型198个(62.9%),非肿块型59个(18.7%),混合型58个(18.4%)。
- 非肿块型浸润性肿瘤尺寸最小(p < 0.001),HER2受体阳性状态最常见(p = 0.001)。
- 混合型脉管侵犯最常见(p = 0.011),腋窝淋巴结阳性最常见(p = 0.031)。
- 混合型手术方式改变最常见(p < 0.001),首次切除切缘阳性最常见(p < 0.001)。
- 非肿块型和混合型初始手术为乳房切除较肿块型更常见(p < 0.001)。
诊断标准与关键数值
- 混合型强化定义为肿块强化与非肿块强化并存。
- HER2受体状态和手术方式改变在多因素分析中无统计学意义。
临床应用与阅片要点
- 阅片时按强化形态将病灶分为肿块型、非肿块型和混合型,混合型需注意脉管侵犯、淋巴结阳性及切缘阳性风险。
- 非肿块型强化者肿瘤尺寸较小但HER2阳性更常见,报告时可提示受体状态相关信息。
- 多因素分析中HER2状态和手术方式改变无统计学意义,解读时应结合其他因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study was conducted in order to evaluate whether enhancement types on preoperative MRI can reflect prognostic factors and surgical outcomes in invasive breast cancer.
METHODS: Among 484 consecutive patients who underwent preoperative breast MRI from October 2014 to July 2017 for biopsy-proven breast cancer, 313 patients with 315 invasive breast cancers who underwent subsequent surgery were finally included in this study. Two radiologists retrospectively reviewed preoperative MRI findings of these 315 lesions and categorized them to mass, nonmass, and combined type according to enhancement features. Combined type was defined as coexisted mass and nonmass enhancement. Histopathologic results focusing on prognostic factors and surgical outcomes were compared among the three types of lesion using Pearson's chi-square, linear-by-linear association, Kruskal-Wallis, one-way ANOVA test, and multinomial logistic regression.
RESULTS: Of the cancers analyzed, 198 (62.9%) were mass, 59 (18.7%) were nonmass, and 58 (18.4%) were combined type. The nonmass type showed the smallest invasive tumor size (p < 0.001) and the most common positive HER2 receptor status (p = 0.001). The combined type had the most frequent lymphovascular invasion (p = 0.011), axillary lymph node-positive status (p = 0.031), operation changes (p < 0.001), and first resection margin-positive status (p < 0.001). Initial operation of mastectomy was more frequent in the nonmass and combined types than that in the mass type (p < 0.001). But HER2 receptor status and operation changes showed no statistical significance on multivariate analysis.
CONCLUSIONS: Enhancement types on preoperative MRI reflect different prognostic factors and surgical outcomes in invasive breast cancer.
KEY POINTS: • Morphologic features of contrast media uptake on contrast-enhanced MRI may be related with fundamental biological differences of invasive breast cancers. • Mass or nonmass enhancement type on preoperative MRI might reflect different prognostic factors and surgical outcomes in invasive breast cancer. • The combined mass and nonmass enhancement type might be associated with poorer prognosis and worse surgical outcomes.
引用
- Koh J, Park AY, Ko KH, et al. Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer? Eur Radiol. 2019. PMID: 31187220. doi:10.1007/s00330-019-06236-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。